Darlene Deptula-Hicks

2021 - F-star Therapeutics

In 2021, Darlene Deptula-Hicks earned a total compensation of $1.1M as Chief Financial Officer, Treasurer and Secretary at F-star Therapeutics, a 16% increase compared to previous year.

Compensation breakdown

Bonus$103,300
Option Awards$145,524
Salary$636,390
Stock Awards$257,100
Total$1,142,314

Deptula-Hicks received $636.4K in salary, accounting for 56% of the total pay in 2021.

Deptula-Hicks also received $103.3K in bonus, $145.5K in option awards and $257.1K in stock awards.

Rankings

In 2021, Darlene Deptula-Hicks' compensation ranked 8,320th out of 12,415 executives tracked by ExecPay. In other words, Deptula-Hicks earned more than 33.0% of executives.

ClassificationRankingPercentile
All
8,320
out of 12,415
33rd
Division
Manufacturing
3,682
out of 5,505
33rd
Major group
Chemicals And Allied Products
1,636
out of 2,375
31st
Industry group
Drugs
1,455
out of 2,096
31st
Industry
Pharmaceutical Preparations
1,083
out of 1,546
30th
Source: SEC filing on April 22, 2022.

Deptula-Hicks' colleagues

We found three more compensation records of executives who worked with Darlene Deptula-Hicks at F-star Therapeutics in 2021.

2021

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2021

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

2021

Neil DSc

F-star Therapeutics

Chief Scientific Officer

News

You may also like